Journal profile · Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
Iranian Biomedical Journal
ISSN 1028-852X · eISSN 2008-823X · Pasteur Institute of Iran · Iran, Islamic Republic of
Iranian Biomedical Journal: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 1.9 (journal website); diamond open access (no APC); no APC; review about 8 weeks (community reports); 39 articles a year; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Iranian Biomedical Journal is published by Pasteur Institute of Iran and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Monoclonal and Polyclonal Antibodies Research and MicroRNA in disease regulation, together about 21.2% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Journal Impact Factor: 1.9 (2025) Iranian Biomedical Journal (IBJ), a bimonthly publication of Pasteur Institute of Iran, is an open access journal (all content is freely available without charge to the user or his/her institution). The Journal follows Creative Commons Attribution-NonDerivatives 4.0 International License (CC BY-ND). The Journal strives to maintain a dynamic growth of the quality of its publications and, therefore, welcomes submissions in the following fields: Molecular Microbiology, Molecular Genetics and Genomics, Molecular Immunology and Vaccines, Cancer Biology, Pharmaceutical Biotechnology, Medical Biotechnology, Enzymology and Protein Chemistry, Tissue Engineering, and related fields IBJ does not accept purely bioinformatics papers without experimental proof Time to First Decision: 10 Days Review Time: 2-3 months Fast Track (Review Processing): 2 weeks
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine8.2%
- Monoclonal and Polyclonal Antibodies ResearchMedicine7.7%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.3%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.3%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology5.3%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.7%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.7%
- Bone Tissue Engineering MaterialsEngineering4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: Index Medicus, Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.9Publisher website ·
- CiteScore 2026-06
- 2.5LetPub ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 108OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 53.15%LetPub ·
Volume
- Articles per year
- 39LetPub ·
Articles by year OpenAlex count · 259 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2024 | 2 | 2 | 0 |
| 2023 | 17 | 17 | 70 |
| 2022 | 32 | 32 | 165 |
| 2021 | 33 | 33 | 239 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to first decision
- 10 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-ND | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePublication ethics, License & copyright
- Publication ethics
Member of COPE Model summary
IBJ is a member of Committee on Publication Ethics (COPE) and follows its guidelines
Source ↗Publisher website ·- License & copyright
CC BY-ND 4.0 license Model summary
The articles of this journal are licensed under a Creative Commons Attribution-NonDerivatives 4.0 International License.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pasteur Institute of Iran
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 1028-852X
- Electronic ISSN
- 2008-823X
- Latest issue on the website
- Volume 30, Issue 4 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Iranian Biomedical Journal
What CAS zone is Iranian Biomedical Journal in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Iranian Biomedical Journal?
The journal's website gives an impact factor of 1.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.5, h-index 27.
How long does peer review take at Iranian Biomedical Journal?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Iranian Biomedical Journal?
According to LetPub and DOAJ records, Iranian Biomedical Journal is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Iranian Biomedical Journal open access, and what is the APC?
Iranian Biomedical Journal is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .